Opioid use disorder (OUD) remains a top public health concern, affecting communities across the world. As the opioid epidemic continues to unravel, the importance of effective and comprehensive treatment options has never been more crucial. This article covers various treatment modalities available for individuals struggling with OUD.

       Medication-assisted treatment (MAT) is a widely recognized and evidence-based approach to managing opioid addiction. MAT combines FDA-approved medications with counseling and behavioral therapies to provide a holistic treatment plan. The medications used in MAT help alleviate withdrawal symptoms, reduce cravings, and normalize brain function without producing the euphoria associated with the abused opioid.

Common Medications in MAT:

1. Methadone: A full opioid agonist, methadone activates the same receptors in the brain as other opioids, preventing withdrawal symptoms and cravings. It is often administered in specialized clinics.

2. Buprenorphine: A partial opioid agonist, buprenorphine helps in reducing cravings and withdrawal symptoms while having a lower potential for abuse. Suboxone, a combination of buprenorphine and naloxone, is commonly prescribed.

3. Naltrexone: An opioid receptor antagonist, naltrexone blocks the effects of opioids and is available in oral and extended-release injectable formulations.

 

Sublocade - A New Option:

       Sublocade, a newer addition to MAT options. It offers a unique and extended-release formulation of buprenorphine. Administered through a monthly injection, Sublocade provides a steady release of medication, eliminating the need for daily oral dosing. This characteristic addresses issues of medication adherence, ensuring a consistent therapeutic effect.  Sublocade is approved by the FDA. 

       Sublocade simplifies the treatment process for individuals with OUD by providing a sustained release of buprenorphine, which helps in preventing relapse and promoting long-term recovery. The convenience and reduced frequency of administration can be particularly beneficial for individuals with busy lifestyles or those struggling with adherence to daily medications.

       Sublocade contains buprenorphine, a partial opioid agonist with a high affinity for opioid receptors. However, unlike full agonists, such as heroin or methadone, buprenorphine's effects plateau at a certain dose, reducing the risk of overdose and abuse. When administered as a monthly injection, Sublocade forms a gel depot under the skin, gradually releasing buprenorphine over the course of a month.  We offer Sublocade at all of Trilogy locations. 

Benefits of Sublocade:

1. Reduced Stigma: The monthly injection format of Sublocade minimizes the visibility of treatment, reducing potential stigma associated with opioid addiction.

2. Improved Adherence: The extended-release nature of Sublocade ensures that individuals receive a consistent dose, addressing issues related to medication adherence.

3. Prevention of Diversion: The formulation of Sublocade makes it less susceptible to diversion or misuse, as the medication is administered as a healthcare professional-monitored injection.

4. Stabilized Treatment: Sublocade helps stabilize individuals in treatment, reducing the risk of relapse and providing a foundation for ongoing recovery.

       MAT, including Sublocade, is most effective when combined with behavioral therapies. Counseling, therapy, and support groups play a crucial role in addressing the psychological aspects of addiction, helping individuals develop coping mechanisms, and providing a supportive environment for recovery.

In Summary

       The battle against opioid use disorder, a comprehensive and individualized approach to treatment is essential. MAT, with its array of medications, has proven to be a cornerstone in addressing the physical aspects of addiction. Sublocade, as an innovative extended-release option, offers additional benefits in terms of convenience, reduced stigma, and improved adherence.

       As the field of addiction medicine continues to evolve, ongoing research and a commitment to understanding the unique needs of individuals with OUD will contribute to refining and expanding treatment options. Ultimately, the goal is to empower individuals to reclaim their lives from the chains of opioid addiction, opening the doorway to a sustained recovery and healthy sober life.